ALS |
amyotrophic lateral sclerosis |
CNS |
central nervous system |
fALS |
familial amyotrophic lateral sclerosis |
sALS |
sporadic amyotrophic lateral sclerosis |
FDA |
Food and Drug Administration |
iPSCs |
induced pluripotent stem cells |
ESCs |
embryonic stem cells |
MNs |
motor neurons |
hiPSCs |
human induced pluripotent stem cells |
iPSCs-MNs |
induced pluripotent stem cells derived motor neurons |
ESCs-MNs |
embryonic stem cells derived motor neurons |
NPCs |
neural progenitor cells |
iPSCs-NPCs |
induced pluripotent stem cells derived neural progenitor cells |
NSCs |
neural stem cells |
iPSCs-NSCs |
induced pluripotent stem cells derived neural stem cells |
NMJ |
neuromuscular junction |
SOD1 |
superoxide dismutase 1 |
C9orf72 |
chromosome nine open reading frame 72 |
TARDBP |
TAR DNA binding protein |
FUS |
fused in sarcoma |
NfH |
neurofilament heavy chain |
NfL |
neurofilament light chain |
CSF |
cerebrospinal fluid |
HD-MEAs |
high density microelectrode-arrays |
DPR |
dipeptide repeat |
TDP-43 |
TAR DNA binding protein 43 |
RNAP II |
RNA polymerase II |
EAAT2 |
excitatory amino acid transporter 2 |
SG |
stress granule |
G3BP1 |
GTPase activating protein (SH3 domain) binding protein 1 |
Il-1α |
interleukin 1α |
TNF |
tumor necrosis factor |
C1q |
complement component 1, subcomponent q |
ROPI |
ropinirole |
HDAC |
histone deacetylase |
FTD |
frontotemporal dementia |
STAT3 |
signal transducer and activator of transcription 3 |
TGF-β |
transforming growth factor-β |